Literature DB >> 15081789

Multiple metabotropic glutamate receptor subtypes modulate GABAergic neurotransmission in rat periaqueductal grey neurons in vitro.

Geoffrey M Drew1, Christopher W Vaughan.   

Abstract

The effect of metabotropic glutamate receptor (mGluR) activation on GABAergic synaptic transmission in rat periaqueductal grey (PAG) neurons was examined using whole-cell patch-clamp recordings in brain slices. The selective groups I, II and III mGluR agonists DHPG (10-30 microM), DCG-IV (1-3 microM) and L-AP4 (10-30 microM) inhibited electrically evoked GABA(A) mediated inhibitory postsynaptic currents (IPSCs) in all PAG neurons tested. DCG-IV and L-AP4 also reduced the frequency of spontaneous IPSCs, while DHPG produced both increases and decreases in spontaneous IPSC frequency in a dose dependent manner. In the presence of TTX, DHPG, DCG-IV and L-AP4 all reduced the frequency of spontaneous miniature IPSCs, but had no effect on their amplitudes. The DHPG, DCG-IV and L-AP4 effects on miniature IPSCs were dose dependent (EC(50)s=1.4, 0.055 and 0.52 microM, respectively) and were reduced by the selective mGluR antagonists MCPG, EGLU and MSOP, respectively. These results indicate that GABAergic synaptic transmission within the PAG is reduced by groups I, II and III mGluR activation via a presynaptic mechanism and is increased by group I mGluR activation via an action potential dependent mechanism. The finding of convergent groups I, II and III mGluR-mediated inhibition of synaptic transmission is novel and indicates that all groups of mGluRs have the potential to modulate the constellation of analgesic, behavioural and autonomic functions within the PAG.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081789     DOI: 10.1016/j.neuropharm.2004.01.015

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  An astrocytic basis of epilepsy.

Authors:  Guo-Feng Tian; Hooman Azmi; Takahiro Takano; Qiwu Xu; Weiguo Peng; Jane Lin; NancyAnn Oberheim; Nanhong Lou; Xiaohai Wang; H Ronald Zielke; Jian Kang; Maiken Nedergaard
Journal:  Nat Med       Date:  2005-08-14       Impact factor: 53.440

2.  mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.

Authors:  Martin Engel; Peta Snikeris; Natalie Matosin; Kelly Anne Newell; Xu-Feng Huang; Elisabeth Frank
Journal:  Psychopharmacology (Berl)       Date:  2016-02-10       Impact factor: 4.530

Review 3.  Cannabinoids in the descending pain modulatory circuit: Role in inflammation.

Authors:  Courtney A Bouchet; Susan L Ingram
Journal:  Pharmacol Ther       Date:  2020-01-29       Impact factor: 12.310

4.  Metabotropic glutamate and GABA receptors modulate cellular excitability and glutamatergic transmission in chicken cochlear nucleus angularis neurons.

Authors:  Wei Shi; Yong Lu
Journal:  Hear Res       Date:  2017-01-16       Impact factor: 3.208

5.  Analgesic Activity of Cinnabarinic Acid in Models of Inflammatory and Neuropathic Pain.

Authors:  Serena Notartomaso; Serena Boccella; N Antenucci; Flavia Ricciardi; Francesco Fazio; F Liberatore; P Scarselli; M Scioli; Giada Mascio; V Bruno; Giuseppe Battaglia; Ferdinando Nicoletti; Sabatino Maione; Livio Luongo
Journal:  Front Mol Neurosci       Date:  2022-06-02       Impact factor: 6.261

6.  Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.

Authors:  Karin R Aubrey; Geoffrey M Drew; Hyo-Jin Jeong; Benjamin K Lau; Christopher W Vaughan
Journal:  J Physiol       Date:  2016-09-15       Impact factor: 5.182

7.  Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway.

Authors:  Geoffrey M Drew; Benjamin K Lau; Christopher W Vaughan
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

8.  NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammation.

Authors:  Toshihiko Yamada; Daiying Zuo; Tatsuo Yamamoto; Rafal T Olszewski; Tomasz Bzdega; John R Moffett; Joseph H Neale
Journal:  Mol Pain       Date:  2012-09-12       Impact factor: 3.395

9.  Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain.

Authors:  Tatsuo Yamamoto; Alan Kozikowski; Jia Zhou; Joseph H Neale
Journal:  Mol Pain       Date:  2008-08-01       Impact factor: 3.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.